Cingulate Inc. (CING) Cash Flow Statement

NASDAQ: CINGOperating cash, capex, free cash flow and buybacks.

Where CING’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$17.2M
Capital expenditures
$162,138
Free cash flow
−$17.4M
Returned to shareholders
—
Change in cash
−$1.3M
cash at year-end $11.0M
Borrowing: $6.0MBorrowing$6.0MShares issued: $10.2MShares issued$10.2MDrawn from cash: $1.3MDrawn from cash$1.3MCash used in operations: $17.2MCash used in operations$17.2M · 99%Capital expenditures: $162,138Capital expenditures$162,138 · 1%$17.4M
Cash from operations
−$17.2M
Capital expenditures
−$162,138
Net borrowing (repayment)
+$6.0M
Shares issued
+$10.2M
Change in cash
−$1.3M

Drawn to scale: where the cash came from and how it was used. Hover for values.

CING operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

CING cash flow trends, 2019–2025

Cingulate Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$9.5M2019−$17.2M2025—
Capital expenditures$1.0M2019$162,1382025−26.3%/yr
Free cash flow−$10.5M2019−$17.4M2025—
Stock-based compensation$02020$1.5M2025—

Change is the average annual growth (CAGR) or the difference between the first and latest year.

CING cash flow by activity

OperatingInvestingFinancingChange in cash

CING net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

CING cash flow statement

Cingulate Inc. annual cash flow statement
2025202420232022202120202019
Operating activities
Net income−$22.4M−$15.5M−$23.5M−$17.7M−$20.7M−$7.2M−$11.5M
Depreciation & amortization$540,894$653,090$582,918$394,011$708,317$666,029$178,912
Stock-based compensation$1.5M$995,484$812,670$800,796$12.8M$0—
Change in working capital$830,852−$4.6M$7.1M$598,617−$3.2M−$293,493$1.9M
Other non-cash items$2.3M$0$0$0$0$0−$48,052
Cash from operating activities−$17.2M−$18.5M−$15.0M−$15.9M−$10.4M−$6.8M−$9.5M
Investing activities
Capital expenditures−$162,138−$211,800−$224,096−$153,420−$814,736−$402,096−$1.0M
Investments (net)—−$211,800−$180,156−$152,652−$814,736$17,922$3.8M
Acquisitions & other investing$138$211,800$180,156$153,420$814,736$0$0
Cash from investing activities−$162,000−$211,800−$224,096−$152,652−$814,736−$384,174$2.7M
Financing activities
Net borrowing (repayment)$6.0M$4.9M$3.0M$5.0M−$936,594$468,083$468,083
Shares issued$10.2M$25.9M$6.2M$218,798$20.4M$0$0
Other financing−$382$0$819,538−$304,717$7.1M$7.5M$5.7M
Cash from financing activities$16.1M$30.8M$10.0M$4.9M$26.5M$8.0M$6.1M
Summary
Net change in cash−$1.3M$12.2M−$5.3M−$11.1M$15.3M$779,202−$644,741
Cash at end of period$11.0M$12.2M$52,416$5.4M$16.5M$1.2M$418,470
Free cash flow−$17.4M−$18.7M−$15.3M−$16.0M−$11.2M−$7.2M−$10.5M

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

CING cash generation

In fiscal 2025 (ended December 31, 2025), Cingulate generated -$17.2 million of cash from operations and spent $0.2 million on capital expenditures, leaving free cash flow of -$17.4 million. Cash and equivalents fell by $1.3 million over the year.

Related: CING income statement, CING balance sheet. See the CING stock overview for the latest quote and news.

CING cash flow FAQ

What is Cingulate's free cash flow?

Cingulate's free cash flow was -$17.4 million in fiscal 2025: -$17.2 million of operating cash flow minus $0.2 million of capital expenditures It was -$18.7 million a year earlier..

How much cash does Cingulate generate from operations?

Cingulate generated -$17.2 million of cash from operating activities in fiscal 2025.

How much does Cingulate spend on capital expenditures?

Cingulate spent $0.2 million on capital expenditures in fiscal 2025, compared with $0.2 million the year before.

Biotechnology: cash flow